 SHANGHAI, April 13, 2021 PRNewswire -- WuXi Biologics WuXi Bio 2269.HK, a global company with leading open-access biologics technology platforms, announced that it has been recognized as the grand winner of the Bioprocessing Excellence in Greater China Region Award in two prestigious categories: the Bioprocessing Excellence in Antibody ADC Therapeutics Manufacturing in Greater China Region and the Bioprocessing Excellence in Viral Clearance and Safety in Greater China Region at the Asia-Pacific Bioprocessing Excellence Awards ABEA 2021. Asia-Pacific Bioprocessing Excellence Awards seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost and superior quality across Asia and the rest of the world. 